399 related articles for article (PubMed ID: 18568076)
1. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.
Reddy P; Sun Y; Toubai T; Duran-Struuck R; Clouthier SG; Weisiger E; Maeda Y; Tawara I; Krijanovski O; Gatza E; Liu C; Malter C; Mascagni P; Dinarello CA; Ferrara JL
J Clin Invest; 2008 Jul; 118(7):2562-73. PubMed ID: 18568076
[TBL] [Abstract][Full Text] [Related]
2. Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.
Colvin BL; Sumpter TL; Tokita D; Salati J; Mellor AL; Thomson AW
Hum Immunol; 2009 May; 70(5):313-20. PubMed ID: 19208362
[TBL] [Abstract][Full Text] [Related]
3. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.
Leng C; Gries M; Ziegler J; Lokshin A; Mascagni P; Lentzsch S; Mapara MY
Exp Hematol; 2006 Jun; 34(6):776-87. PubMed ID: 16728283
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.
Choi SW; Gatza E; Hou G; Sun Y; Whitfield J; Song Y; Oravecz-Wilson K; Tawara I; Dinarello CA; Reddy P
Blood; 2015 Jan; 125(5):815-9. PubMed ID: 25428224
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice.
Misaki K; Morinobu A; Saegusa J; Kasagi S; Fujita M; Miyamoto Y; Matsuki F; Kumagai S
Arthritis Res Ther; 2011 May; 13(3):R77. PubMed ID: 21592365
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.
Li J; Meinhardt A; Roehrich ME; Golshayan D; Dudler J; Pagnotta M; Trucco M; Vassalli G
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3415-23. PubMed ID: 17933973
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3.
Sun Y; Chin YE; Weisiger E; Malter C; Tawara I; Toubai T; Gatza E; Mascagni P; Dinarello CA; Reddy P
J Immunol; 2009 May; 182(10):5899-903. PubMed ID: 19414739
[TBL] [Abstract][Full Text] [Related]
8. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.
Bosisio D; Vulcano M; Del Prete A; Sironi M; Salvi V; Salogni L; Riboldi E; Leoni F; Dinarello CA; Girolomoni G; Sozzani S
J Leukoc Biol; 2008 Dec; 84(6):1540-8. PubMed ID: 18780875
[TBL] [Abstract][Full Text] [Related]
9. HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen.
Li N; Zhao D; Kirschbaum M; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4796-801. PubMed ID: 18347343
[TBL] [Abstract][Full Text] [Related]
10. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells transfected with indoleamine 2,3-dioxygenase gene suppressed acute rejection of cardiac allograft.
Li C; Liu T; Zhao N; Zhu L; Wang P; Dai X
Int Immunopharmacol; 2016 Jul; 36():31-38. PubMed ID: 27107370
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibition and graft versus host disease.
Choi S; Reddy P
Mol Med; 2011; 17(5-6):404-16. PubMed ID: 21298214
[TBL] [Abstract][Full Text] [Related]
14. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
[TBL] [Abstract][Full Text] [Related]
15. LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in mice.
Wang D; Iclozan C; Liu C; Xia C; Anasetti C; Yu XZ
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1182-1190.e1. PubMed ID: 22698484
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models.
Bianco NR; Kim SH; Ruffner MA; Robbins PD
Arthritis Rheum; 2009 Feb; 60(2):380-9. PubMed ID: 19180475
[TBL] [Abstract][Full Text] [Related]
17. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
[TBL] [Abstract][Full Text] [Related]
18. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
Lu Y; Giver CR; Sharma A; Li JM; Darlak KA; Owens LM; Roback JD; Galipeau J; Waller EK
Blood; 2012 Jan; 119(4):1075-85. PubMed ID: 22130799
[TBL] [Abstract][Full Text] [Related]
20. An HDAC inhibitor enhances cancer therapeutic efficiency of RNA polymerase III promoter-driven IDO shRNA.
Yen MC; Weng TY; Chen YL; Lin CC; Chen CY; Wang CY; Chao HL; Chen CS; Lai MD
Cancer Gene Ther; 2013 Jun; 20(6):351-7. PubMed ID: 23681283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
